Reply to thread

Message

<blockquote data-quote="tD33NAt" data-source="post: 2576972" data-attributes="member: 124445">VIVUS, Inc. (NASDAQ: VVUS) announced that additional data from the phase 3 QNEXA studies will be presented during the American Association of Diabetes Educators (AADE) meeting in Las Vegas, NV.&nbsp; Ronette L. Kolotkin, PhD, a clinical psychologist from Obesity and Quality of Life Consulting, Consulting Professor at Duke University Medical Center, and former Director of the Behavioral Program at Duke University&#039;s Diet &amp; Fitness Center, will give an oral presentation today entitled, &quot;Quality of Life is Improved With Controlled-Release Phentermine/Topiramate In Overweight and Obese Patients.&quot; Dr...<img src="http://feeds.feedburner.com/~r/mnt/healthnews/~4/e8607uzpixY" alt="" class="fr-fic fr-dii fr-draggable " data-size="" style="" /><a href="http://feedproxy.google.com/~r/mnt/healthnews/~3/e8607uzpixY/232383.php" target="_blank">More...</a></blockquote>

[QUOTE="tD33NAt, post: 2576972, member: 124445"] VIVUS, Inc. (NASDAQ: VVUS) announced that additional data from the phase 3 QNEXA studies will be presented during the American Association of Diabetes Educators (AADE) meeting in Las Vegas, NV. Ronette L. Kolotkin, PhD, a clinical psychologist from Obesity and Quality of Life Consulting, Consulting Professor at Duke University Medical Center, and former Director of the Behavioral Program at Duke University's Diet & Fitness Center, will give an oral presentation today entitled, "Quality of Life is Improved With Controlled-Release Phentermine/Topiramate In Overweight and Obese Patients." Dr...[IMG]http://feeds.feedburner.com/~r/mnt/healthnews/~4/e8607uzpixY[/IMG] [url=http://feedproxy.google.com/~r/mnt/healthnews/~3/e8607uzpixY/232383.php]More...[/url] [/QUOTE]

Name

Verification

Loading…